-+ 0.00%
-+ 0.00%
-+ 0.00%

Nurix Therapeutics shareholders ratify PwC as auditor for fiscal 2026

PUBT·05/15/2026 20:07:17
Listen to the news
Nurix Therapeutics shareholders ratify PwC as auditor for fiscal 2026
  • Nurix Therapeutics held its annual shareholder meeting on May 15, 2026.
  • Shareholders ratified PricewaterhouseCoopers as independent registered public accounting firm for fiscal year ending Nov. 30, 2026.
  • Votes also backed appointment of three directors to new terms running through 2029.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001549595-26-000028), on May 15, 2026, and is solely responsible for the information contained therein.